RT Journal Article
SR Electronic
T1 Long-term impacts of an urban sanitation intervention on enteric pathogens in children in Maputo city, Mozambique: study protocol for a cross-sectional follow-up to the Maputo Sanitation (MapSan) trial five years post-intervention
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.08.19.22278991
DO 10.1101/2022.08.19.22278991
A1 Holcomb, David
A1 Monteiro, Vanessa
A1 Capone, Drew
A1 António, Virgílio
A1 Chiluvane, Márcia
A1 Cumbane, Victória
A1 Ismael, Nália
A1 Knee, Jackie
A1 Kowalsky, Erin
A1 Lai, Amanda
A1 Linden, Yarrow
A1 Mataveia, Elly
A1 Nalá, Rassul
A1 Rao, Gouthami
A1 Ribeiro, Jorge
A1 Cumming, Oliver
A1 Viegas, Edna
A1 Brown, Joe
YR 2022
UL http://medrxiv.org/content/early/2022/08/22/2022.08.19.22278991.abstract
AB Background We previously assessed the effect of an onsite sanitation intervention in informal neighborhoods of urban Maputo, Mozambique on enteric pathogen detection in children after two years of follow-up (Maputo Sanitation [MapSan] trial, clinicaltrials.gov: NCT02362932). We found significant reductions in Shigella and Trichuris prevalence but only among children born after the intervention was delivered. In this study, we assess the health impacts of the sanitation intervention after five years among children born into study households post-intervention.Methods We are conducting a cross-sectional household study of enteric pathogen detection in child stool and the environment in the 16 MapSan study neighborhoods at compounds (household clusters sharing sanitation and outdoor living space) that received the pour-flush toilet and septic tank intervention at least five years prior or meet the original criteria for trial control sites. We are enrolling at least 400 children (ages 29 days – 60 months) in each treatment arm. Our primary outcome is the prevalence of 22 bacterial, protozoan, and soil transmitted helminth (STH) enteric pathogens in child stool using the pooled odds ratio across the outcome set to assess the intervention effect. Secondary outcomes include the individual pathogen detection prevalence and gene copy density of 27 enteric pathogens (including viruses); mean height-for-age (HAZ), weight-for-age (WAZ), and weight-for-height (WHZ) z-scores; prevalence of stunting, underweight, and wasting; and the 7-day period-prevalence of caregiver-reported diarrhea. All analyses are adjusted for pre-specified covariates and examined for effect measure modification by age. Environmental samples from study households and the public domain are assessed for pathogens and fecal indicators to explore environmental exposures and monitor disease transmission.Discussion We are using stool-based detection of multiple enteric pathogens as an objective measure of exposure to evaluate an existing sanitation intervention. We propose a novel pooled estimate of the treatment effect across a pre-specified outcome set to summarize the overall impact of the intervention on enteric pathogen exposure as the primary trial outcome.Trial Registration This trial was prospectively registered on 16 March 2022 (ISRCTN86084138).Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study is funded by the Bill & Melinda Gates Foundation (OPP1137224) with additional support from a National Institute of Environmental Health Sciences training grant (T32ES007018). The funders had no role in the study design; data collection, analysis, and interpretation; or decision to publish.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The National Health Bioethics Committee of the Ministry of Health of Mozambique gave ethical approval for this work (FWA#: 00003139, IRB00002657, 326/CNBS/21; approved: 15 June 2021) The Institutional Review Board of University of North Carolina at Chapel Hill gave ethical approval for this work (IRB#: 21-1119; approved 19 August 2021)I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThis is the protocol for an ongoing study. Upon publication of study results, the underlying individual participant data will be fully de-identified according to the Safe Harbor method and made freely available in a permanent online repository (https://osf.io/e7pvk/) in accordance with the funder’s open data policies. https://osf.io/e7pvk/ AbbreviationDescriptionCISPOCCentro de Investigação e Treino em Saúde da Polana Caniço (Polana Caniço Health Research and Training Center)CSBcommunal sanitation blockEAECenteroaggregative E. coliEEDenvironmental enteric dysfunctionEIECenteroinvasive E. coliEMMeffect measure modificationEPECenteropathogenic E. coliETECenterotoxigenic E. coliFSTfecal source trackingGEEgeneralized estimating equationsGEMSGlobal Enteric Multicenter StudyHAZheight-for-age z-scoreICCintra-class correlation coefficientINSInstituto Nacional de Saúde (National Institute of Health, Republic of Mozambique)LMIClow- and middle-income countriesLSHTMLondon School of Hygiene and Tropical MedicineMapSanMaputo Sanitation trialMDESminimum detectable effect sizeNGOnongovernmental organizationPDprevalence differencePORprevalence odds ratioPRprevalence ratioRT-qPCRReverse-transcription quantitative [real-time] polymerase chain reactionSESsocioeconomic statusSLshared latrineSTECShiga toxin-producing E. coliSTHsoil transmitted helminthTACTaqMan Array CardUNCUniversity of North Carolina at Chapel HillWASHwater, sanitation, and hygieneWAZweight-for-age z-scoreWHOWorld Health OrganizationWHZweight-for-height z-scoreWSPWater and Sanitation ProgrammeWSUPWater and Sanitation for the Urban Poor